HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist
  • 43.700
  • -1.050-2.35%
Market Closed Nov 12 16:08 CST
12.22BMarket Cap-15017P/E (TTM)

KEYMED BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KEYMED BIO-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 545.951M --
-- 2024/FY -- / 126.803M --
Mar 26, 2024 2023/FY 354.095M / 356.052M --
Mar 17, 2023 2022/FY 100.063M / 128.000M --
Mar 29, 2022 2021/FY 110.269M / 80.000M --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 545.951M--
--2024/FY-- / 126.803M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
Mar 29, 20222021/FY110.269M / 80.000M--

Unlock Free Earnings Estimates

KEYMED BIO-B Earnings Reports

  • KEYMED BIO-B: 2024 INTERIM REPORT

    Sep 23 21:01

  • KEYMED BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024

    Aug 27 18:23

  • KEYMED BIO-B: DATE OF BOARD MEETING

    Aug 15 16:35

  • KEYMED BIO-B: 2023 ANNUAL REPORT

    Apr 24 16:30

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Strong Buy

      87.50%

    • Buy

      12.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg

    No Data